354 related articles for article (PubMed ID: 28425869)
1. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
2. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
4. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
5. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
[TBL] [Abstract][Full Text] [Related]
6. Investigation of inclusion complex of honokiol with sulfobutyl ether-β-cyclodextrin.
Xu C; Tang Y; Hu W; Tian R; Jia Y; Deng P; Zhang L
Carbohydr Polym; 2014 Nov; 113():9-15. PubMed ID: 25256452
[TBL] [Abstract][Full Text] [Related]
7. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
9. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
10. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
12. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
[TBL] [Abstract][Full Text] [Related]
14. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
Nagarwal RC; Kumar R; Pandit JK
Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
[TBL] [Abstract][Full Text] [Related]
15. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery.
Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N
Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201
[TBL] [Abstract][Full Text] [Related]
16. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.
Nagarwal RC; Singh PN; Kant S; Maiti P; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(2):272-8. PubMed ID: 21297311
[TBL] [Abstract][Full Text] [Related]
17. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
Fülöp Z; Saokham P; Loftsson T
Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
[TBL] [Abstract][Full Text] [Related]
18. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D
Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821
[TBL] [Abstract][Full Text] [Related]
19. A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan.
Li X; Zheng X; Wei X; Guo G; Gou M; Gong C; Wang X; Dai M; Chen L; Wei Y; Qian Z
J Nanosci Nanotechnol; 2009 Aug; 9(8):4586-92. PubMed ID: 19928122
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]